Founder BRCA 1 and 2 Mutations among a Consecutive Series of Ashkenazi Jewish Ovarian Cancer Patients

By Tobias D.H.   Eng C.   McCurdy L.D.   Kalir T.   Mandelli J.   Dottino P.R.   Cohen C.J.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 148-151

Elsevier

Access to resources Recommend Favorite

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

By Beller U.   Halle D.   Catane R.   Kaufman B.   Hornreich G.   Levy-Lahad E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

The 1100delAT BRCA1 and the 8765delAG BRCA2 Mutations: Occurrence in High-Risk Non-Ashkenazi Jews and Haplotype Comparison of Jewish and Non-Jewish Carriers

By Gal Inbar   Baruch Ruth Gershoni   Haber Daniel   Dagan Efrat   Eisenberg-Barzilai Shlomit   Zidan Jamal   Friedman Eitan  

Familial Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 11-14

Springer Publishing Company

Access to resources Recommend Favorite

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite